Study examines treatments for relieving breathing difficulties among patients with lung effusions

May 20, 2012

Helen E. Davies, M.D., of the University Hospital of Wales, Cardiff, and colleagues compared the effectiveness of treatments to relieve breathing difficulties among patients with malignant pleural effusion (presence of fluid in the pleural cavity [space between the outside of the lungs and the inside wall of the chest cavity], as a complication of malignant disease). The treatments compared were chest tube drainage and talc slurry for pleurodesis (a procedure in which the pleural space is obliterated) vs. indwelling pleural catheters (IPCs).

Malignant pleural effusion causes disabling dyspnea () in more than 1 million people worldwide annually; patients have an of 4 months. "There are no robust clinical data to address which of these treatments is more effective at palliating symptoms and improving quality of life," the authors write. "Indwelling pleural catheters are increasingly used as an alternative treatment to talc pleurodesis."

The compared IPC (n = 52) and talc slurry for pleurodesis (n = 54) for patients with malignant pleural effusion who were treated at 7 U.K. hospitals. Patients were screened from April 2007-February 2011 and were followed up for a year. The researchers found that there was no significant difference between groups in dyspnea in the first 42 days after intervention. Indwelling pleural catheters reduced time in the hospital but were associated with an excess of adverse events. "As such, IPCs cannot be advocated as a superior treatment to talc pleurodesis for palliation of symptoms," the authors write.

Explore further: Talcum powder stunts growth of lung tumors

More information: JAMA, doi:10.1001/JAMA. 2012.5535

Related Stories

Talcum powder stunts growth of lung tumors

June 6, 2007

Talcum powder has been used for generations to soothe babies’ diaper rash and freshen women’s faces. But University of Florida researchers report the household product has an additional healing power: The ability to stunt ...

Court ruling hurts asbestos workers

October 19, 2007

Welsh factory workers who suffer scarring of the lung tissue from asbestos may have lost their right to file for compensation.

New test offers better diagnosis of asbestos cancer

August 26, 2009

(PhysOrg.com) -- A new test can significantly improve diagnosis of the asbestos-related cancer mesothelioma, a joint team from the University of Oxford and the Oxford Centre for Respiratory Medicine at the John Radcliffe ...

New two-drug approach to treat type of respiratory disease

August 11, 2011

(Medical Xpress) -- A therapy combining two existing drugs could provide an effective new approach for treating patients with pleural infections, a serious condition where infected fluid builds up in the space between the ...

Recommended for you

New drug to fight fatal but neglected tropical disease

August 31, 2016

In a breakthrough for those infected by the parasites that cause sleeping sickness, a young Queensland researcher has identified a compound that kills the parasites in the lab without having any toxic effect on human cells.

Traces of Ebola virus linger longer than expected in semen

August 31, 2016

Initial data from a Liberian public health program show about 9 percent (38) of 429 male Ebola survivors had fragments of Ebola virus in their semen. Of those, 63 percent had semen samples that tested positive for Ebola fragments ...

Researchers discover a drug for a tropical disease

August 30, 2016

Researchers at the University of Georgia are working to find the fastest way possible to treat and cure human African trypanosomiasis, long referred to as sleeping sickness. By working to improve chemical entities already ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.